Kempf DJ - Search Results

1

Pharmacokinetic-pharmacodynamic analysis of lopinavir-ritonavir in combination with efavirenz and two nucleoside reverse transcriptase inhibitors in extensively pretreated human immunodeficiency virus-infected patients.

Hsu A, Isaacson J, Brun S, Bernstein B, Lam W, Bertz R, Foit C, Rynkiewicz K, Richards B, King M, Rode R, Kempf DJ, Granneman GR, Sun E. Hsu A, et al. Among authors: kempf dj. Antimicrob Agents Chemother. 2003 Jan;47(1):350-9. doi: 10.1128/AAC.47.1.350-359.2003. Antimicrob Agents Chemother. 2003. PMID: 12499212 Free PMC article. Clinical Trial.

2

In vitro antiviral interaction of lopinavir with other protease inhibitors.

Molla A, Mo H, Vasavanonda S, Han L, Lin CT, Hsu A, Kempf DJ. Molla A, et al. Among authors: kempf dj. Antimicrob Agents Chemother. 2002 Jul;46(7):2249-53. doi: 10.1128/AAC.46.7.2249-2253.2002. Antimicrob Agents Chemother. 2002. PMID: 12069982 Free PMC article.

3

Virtual inhibitory quotient predicts response to ritonavir boosting of indinavir-based therapy in human immunodeficiency virus-infected patients with ongoing viremia.

Shulman N, Zolopa A, Havlir D, Hsu A, Renz C, Boller S, Jiang P, Rode R, Gallant J, Race E, Kempf DJ, Sun E. Shulman N, et al. Among authors: kempf dj. Antimicrob Agents Chemother. 2002 Dec;46(12):3907-16. doi: 10.1128/AAC.46.12.3907-3916.2002. Antimicrob Agents Chemother. 2002. PMID: 12435695 Free PMC article.

4

Analysis of the virological response with respect to baseline viral phenotype and genotype in protease inhibitor-experienced HIV-1-infected patients receiving lopinavir/ritonavir therapy.

Kempf DJ, Isaacson JD, King MS, Brun SC, Sylte J, Richards B, Bernstein B, Rode R, Sun E. Kempf DJ, et al. Antivir Ther. 2002 Sep;7(3):165-74. Antivir Ther. 2002. PMID: 12487383 Clinical Trial.

5

Incidence of resistance in a double-blind study comparing lopinavir/ritonavir plus stavudine and lamivudine to nelfinavir plus stavudine and lamivudine.

Kempf DJ, King MS, Bernstein B, Cernohous P, Bauer E, Moseley J, Gu K, Hsu A, Brun S, Sun E. Kempf DJ, et al. J Infect Dis. 2004 Jan 1;189(1):51-60. doi: 10.1086/380509. Epub 2003 Dec 31. J Infect Dis. 2004. PMID: 14702153 Clinical Trial.

6

Estimation of serum-free 50-percent inhibitory concentrations for human immunodeficiency virus protease inhibitors lopinavir and ritonavir.

Hickman D, Vasavanonda S, Nequist G, Colletti L, Kati WM, Bertz R, Hsu A, Kempf DJ. Hickman D, et al. Among authors: kempf dj. Antimicrob Agents Chemother. 2004 Aug;48(8):2911-7. doi: 10.1128/AAC.48.8.2911-2917.2004. Antimicrob Agents Chemother. 2004. PMID: 15273100 Free PMC article.

7

Selection of resistance in protease inhibitor-experienced, human immunodeficiency virus type 1-infected subjects failing lopinavir- and ritonavir-based therapy: mutation patterns and baseline correlates.

Mo H, King MS, King K, Molla A, Brun S, Kempf DJ. Mo H, et al. Among authors: kempf dj. J Virol. 2005 Mar;79(6):3329-38. doi: 10.1128/JVI.79.6.3329-3338.2005. J Virol. 2005. PMID: 15731227 Free PMC article. Clinical Trial.

8

Relationship between adherence and the development of resistance in antiretroviral-naive, HIV-1-infected patients receiving lopinavir/ritonavir or nelfinavir.

King MS, Brun SC, Kempf DJ. King MS, et al. Among authors: kempf dj. J Infect Dis. 2005 Jun 15;191(12):2046-52. doi: 10.1086/430387. Epub 2005 May 12. J Infect Dis. 2005. PMID: 15897990 Clinical Trial.

9

Predictive genotypic algorithm for virologic response to lopinavir-ritonavir in protease inhibitor-experienced patients.

King MS, Rode R, Cohen-Codar I, Calvez V, Marcelin AG, Hanna GJ, Kempf DJ. King MS, et al. Among authors: kempf dj. Antimicrob Agents Chemother. 2007 Sep;51(9):3067-74. doi: 10.1128/AAC.00388-07. Epub 2007 Jun 18. Antimicrob Agents Chemother. 2007. PMID: 17576846 Free PMC article. Clinical Trial.

10

In vitro selection and characterization of human immunodeficiency virus type 2 with decreased susceptibility to lopinavir.

Masse S, Lu X, Dekhtyar T, Lu L, Koev G, Gao F, Mo H, Kempf D, Bernstein B, Hanna GJ, Molla A. Masse S, et al. Antimicrob Agents Chemother. 2007 Sep;51(9):3075-80. doi: 10.1128/AAC.00146-07. Epub 2007 Jun 18. Antimicrob Agents Chemother. 2007. PMID: 17576848 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

140 results

Search Page

Filters